Cost of integrated chronic care for severe non-communicable diseases at district hospitals in rural Rwanda.

cost-analysis integrated delivery of health care noncommunicable diseases sub-saharan africa

Journal

BMJ global health
ISSN: 2059-7908
Titre abrégé: BMJ Glob Health
Pays: England
ID NLM: 101685275

Informations de publication

Date de publication:
2019
Historique:
received: 30 01 2019
revised: 29 04 2019
accepted: 04 05 2019
entrez: 20 7 2019
pubmed: 20 7 2019
medline: 20 7 2019
Statut: epublish

Résumé

Integrated clinical strategies to address non-communicable disease (NCDs) in sub-Saharan Africa have largely been directed to prevention and treatment of common conditions at primary health centres. This study examines the cost of organising integrated nurse-driven, physician-supervised chronic care for more severe NCDs at an outpatient specialty clinic associated with a district hospital in rural Rwanda. Conditions addressed included type 1 and type 2 diabetes, chronic respiratory disease, heart failure and rheumatic heart disease. A retrospective costing analysis was conducted from the facility perspective using data from administrative sources and the electronic medical record systems of Butaro District Hospital in rural Rwanda. We determined initial start-up and annual operating financial cost of the Butaro district advanced NCD clinic for the fiscal year 2013-2014. Per-patient annual cost by disease category was determined. A total of US$47 976 in fixed start-up costs was necessary to establish a new advanced NCD clinic serving a population of approximately 300 000 people (US$0.16 per capita). The additional annual operating cost for this clinic was US$68 975 (US$0.23 per capita) to manage a 632-patient cohort and provide training, supervision and mentorship to primary health centres. Labour comprised 54% of total cost, followed by medications at 17%. Diabetes mellitus had the highest annual cost per patient (US$151), followed by heart failure (US$104), driven primarily by medication therapy and laboratory testing. This is the first study to evaluate the costs of integrated, decentralised chronic care for some severe NCDs in rural sub-Saharan Africa. The findings show that these services may be affordable to governments even in the most constrained health systems.

Sections du résumé

BACKGROUND BACKGROUND
Integrated clinical strategies to address non-communicable disease (NCDs) in sub-Saharan Africa have largely been directed to prevention and treatment of common conditions at primary health centres. This study examines the cost of organising integrated nurse-driven, physician-supervised chronic care for more severe NCDs at an outpatient specialty clinic associated with a district hospital in rural Rwanda. Conditions addressed included type 1 and type 2 diabetes, chronic respiratory disease, heart failure and rheumatic heart disease.
METHODS METHODS
A retrospective costing analysis was conducted from the facility perspective using data from administrative sources and the electronic medical record systems of Butaro District Hospital in rural Rwanda. We determined initial start-up and annual operating financial cost of the Butaro district advanced NCD clinic for the fiscal year 2013-2014. Per-patient annual cost by disease category was determined.
RESULTS RESULTS
A total of US$47 976 in fixed start-up costs was necessary to establish a new advanced NCD clinic serving a population of approximately 300 000 people (US$0.16 per capita). The additional annual operating cost for this clinic was US$68 975 (US$0.23 per capita) to manage a 632-patient cohort and provide training, supervision and mentorship to primary health centres. Labour comprised 54% of total cost, followed by medications at 17%. Diabetes mellitus had the highest annual cost per patient (US$151), followed by heart failure (US$104), driven primarily by medication therapy and laboratory testing.
CONCLUSIONS CONCLUSIONS
This is the first study to evaluate the costs of integrated, decentralised chronic care for some severe NCDs in rural sub-Saharan Africa. The findings show that these services may be affordable to governments even in the most constrained health systems.

Identifiants

pubmed: 31321086
doi: 10.1136/bmjgh-2019-001449
pii: bmjgh-2019-001449
pmc: PMC6597643
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e001449

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Lancet. 2003 Mar 1;361(9359):717-25
pubmed: 12620735
Trials. 2011 Jan 05;12:3
pubmed: 21205325
JACC Heart Fail. 2013 Jun;1(3):230-6
pubmed: 24621875
Bull World Health Organ. 2014 Jun 1;92(6):389
pubmed: 24940009
Lancet Diabetes Endocrinol. 2015 Jun;3(6):402-403
pubmed: 26003752
Lancet. 2015 Sep 26;386(10000):1221-1222
pubmed: 26403914
Healthc (Amst). 2015 Dec;3(4):215-20
pubmed: 26699346
Heart. 2017 Dec;103(23):1874-1879
pubmed: 28490619
Lancet Glob Health. 2017 Sep;5(9):e875-e887
pubmed: 28728918
Int J Tuberc Lung Dis. 2017 Oct 1;21(10):1176-1182
pubmed: 28766486
J Diabetes Res. 2017;2017:2657820
pubmed: 29362719
Lancet. 2018 May 19;391(10134):2071-2078
pubmed: 29627159
Heart. 2018 Oct;104(20):1707-1713
pubmed: 29678896
Circ Cardiovasc Qual Outcomes. 2018 Dec;11(12):e004881
pubmed: 30562070
J Am Coll Cardiol. 2019 Mar 5;73(8):977-980
pubmed: 30819366

Auteurs

Lauren Anne Eberly (LA)

Department of Medicine, Division of Global Health Equity, Brigham and Women's Hospital, Boston, Massachusetts, USA.

Christian Rusangwa (C)

Inshuti Mu Buzima, Partners In Health - Rwanda, Rwinkwavu, Rwanda.

Loise Ng'ang'a (L)

Inshuti Mu Buzima, Partners In Health - Rwanda, Rwinkwavu, Rwanda.

Claire C Neal (CC)

Organizational Transformational Initiatives, Greenville, South Carolina, USA.

Jean Paul Mukundiyukuri (JP)

Inshuti Mu Buzima, Partners In Health - Rwanda, Rwinkwavu, Rwanda.

Egide Mpanusingo (E)

Inshuti Mu Buzima, Partners In Health - Rwanda, Rwinkwavu, Rwanda.

Jean Claude Mungunga (JC)

Partners In Health, Boston, Massachusetts, USA.

Hamissy Habineza (H)

Inshuti Mu Buzima, Partners In Health - Rwanda, Rwinkwavu, Rwanda.

Todd Anderson (T)

Inshuti Mu Buzima, Partners In Health - Rwanda, Rwinkwavu, Rwanda.

Gedeon Ngoga (G)

Inshuti Mu Buzima, Partners In Health - Rwanda, Rwinkwavu, Rwanda.

Symaque Dusabeyezu (S)

Inshuti Mu Buzima, Partners In Health - Rwanda, Rwinkwavu, Rwanda.

Gene Kwan (G)

Department of Medicine, Section of Cardiology, Boston University, Boston, Massachusetts, USA.
Department of Global Health and Social Medicine, Program in Global NCDs and Social Change, Harvard Medical School, Boston, Massachusetts, USA.

Charlotte Bavuma (C)

Inshuti Mu Buzima, Partners In Health - Rwanda, Rwinkwavu, Rwanda.
Department of Internal Medicine, Endocrinology Unit, School of Medicine and Pharmacy, College of Medicine and Health Sciences, University of Rwanda, Kigali, Rwanda.

Emmanual Rusingiza (E)

Inshuti Mu Buzima, Partners In Health - Rwanda, Rwinkwavu, Rwanda.
Department of Pediatrics, Pediatric Cardiology Unit, School of Medicine and Pharmacy, College of Medicine and Health Sciences, University of Rwanda, Kigali, Rwanda.

Francis Mutabazi (F)

Inshuti Mu Buzima, Partners In Health - Rwanda, Rwinkwavu, Rwanda.

Joseph Mucumbitsi (J)

Department of Paediatrics, King Faisal Hospital, Kigali, Rwanda.

Cyprien Gahamanyi (C)

Inshuti Mu Buzima, Partners In Health - Rwanda, Rwinkwavu, Rwanda.

Cadet Mutumbira (C)

Inshuti Mu Buzima, Partners In Health - Rwanda, Rwinkwavu, Rwanda.

Paul H Park (PH)

Partners In Health, Boston, Massachusetts, USA.
Department of Global Health and Social Medicine, Program in Global NCDs and Social Change, Harvard Medical School, Boston, Massachusetts, USA.

Tharcisse Mpunga (T)

Ministry of Health, Kigali, Rwanda.

Gene Bukhman (G)

Department of Medicine, Division of Global Health Equity, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Partners In Health, Boston, Massachusetts, USA.
Department of Global Health and Social Medicine, Program in Global NCDs and Social Change, Harvard Medical School, Boston, Massachusetts, USA.

Classifications MeSH